Assessment of oral S+ ketamine associated with morphine for the treatment of oncologic pain
- PMID: 19468615
- DOI: 10.1590/s0034-70942007000100003
Assessment of oral S+ ketamine associated with morphine for the treatment of oncologic pain
Abstract
Background and objectives: Morphine is used frequently to treat oncologic pain. However, tolerance may develop with prolonged use. The association of a NMDA receptor antagonist may reduce or delay the onset of tolerance. S(+) ketamine seems to be more potent and with fewer side effects. The aim of this study was to evaluate the association of S(+) ketamine and morphine in the treatment of oncologic pain.
Methods: Thirty patients, randomly divided in two groups, participated in this double-blind study. Patients in G1 received 10 mg of morphine PO every 6 hours and 10 mg of S(+) ketamine PO every 8 hours. Patients in G2 received 10 mg of morphine PO every 6 hours and placebo PO every 8 hours. The dose of morphine was adjusted by 5 mg increments whenever necessary. Pain severity was evaluated through a verbal scale.
Results: The percentage of no pain and mild pain was similar in both groups (G1 = 0 and G2 = 0 at M0; G1 = 22.2 and G2 = 53.8 at M1; G1 = 22.2 and G2 = 61.5 at M2; G1 = 44.6 and G2 = 61.5 at M3; and G1 = 44.5 and G2 = 53.8 at M4); Chi-square test. The percentage of moderate relief and complete relief was similar in both groups (G1 = 33.4 and G2 = 53.9 after one week; G1 = 44.4 and G2 = 69.2 after two weeks; G1 = 66.6 and G2 = 69.2 after three weeks; and G1 = 55.6 and G2 = 53.9 after four weeks); Chi-square test. The need to increase the dose of morphine was also similar in both groups (G1 = 2.22 and G2 = 2.15); Mann-Whitney test.
Conclusions: We did not observe an increase on the analgesic effects of morphine with the association of 10 mg of S(+) ketamine PO in the treatment of oncologic pain.
Similar articles
-
Assessment of the effect of ketamine in combination with remifentanil on postoperative pain.Braz J Anesthesiol. 2013 Mar-Apr;63(2):178-82. doi: 10.1016/j.bjane.2012.02.005. Epub 2013 Aug 13. Braz J Anesthesiol. 2013. PMID: 24565123 Clinical Trial.
-
Assessment of the effect of ketamine in combination with remifentanil on postoperative pain.Braz J Anesthesiol. 2013 Mar-Apr;63(2):178-82. doi: 10.1016/S0034-7094(13)70211-3. Braz J Anesthesiol. 2013. PMID: 23601257 Clinical Trial.
-
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.Acta Anaesthesiol Scand. 2009 Sep;53(8):1073-83. doi: 10.1111/j.1399-6576.2009.02039.x. Epub 2009 Jun 30. Acta Anaesthesiol Scand. 2009. PMID: 19572933 Clinical Trial.
-
Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial.Acad Emerg Med. 2014 Nov;21(11):1193-202. doi: 10.1111/acem.12510. Acad Emerg Med. 2014. PMID: 25377395 Clinical Trial.
-
Remifentanil in combination with ketamine versus remifentanil in spinal fusion surgery--a double blind study.Int J Clin Pharmacol Ther. 2010 Aug;48(8):542-8. doi: 10.5414/cpp48542. Int J Clin Pharmacol Ther. 2010. PMID: 20650046 Clinical Trial.
Cited by
-
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018 Jul;43(5):521-546. doi: 10.1097/AAP.0000000000000808. Reg Anesth Pain Med. 2018. PMID: 29870458 Free PMC article. Review.
-
The role of ketamine in the treatment of chronic cancer pain.Clujul Med. 2015;88(4):457-61. doi: 10.15386/cjmed-500. Epub 2015 Nov 15. Clujul Med. 2015. PMID: 26733743 Free PMC article. Review.
-
Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome.Am J Hosp Palliat Care. 2012 Jun;29(4):308-17. doi: 10.1177/1049909111416345. Epub 2011 Jul 29. Am J Hosp Palliat Care. 2012. PMID: 21803784 Free PMC article. Review.
-
Ketamine as an adjuvant to opioids for cancer pain.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD003351. doi: 10.1002/14651858.CD003351.pub3. Cochrane Database Syst Rev. 2017. PMID: 28657160 Free PMC article. Review.
-
The Efficacy of Ketamine for Acute and Chronic Pain in Patients with Cancer: A Systematic Review of Randomized Controlled Trials.Healthcare (Basel). 2024 Aug 6;12(16):1560. doi: 10.3390/healthcare12161560. Healthcare (Basel). 2024. PMID: 39201120 Free PMC article. Review.